May 10, 2017
A New York federal judge on Wednesday awarded investment banking advisory firm Peter J. Solomon Co. LP nearly $5 million in fees and interest from the $200 million sale of the British biotech formerly known as Spirogen Ltd. to an to an AstraZeneca PLC subsidiary.
July 23, 2015
The British biotech formerly known as Spirogen Ltd. pressed a New York federal judge Wednesday to ditch investment banking advisory firm Peter J. Solomon Co.'s suit seeking fees from the company's $200 million sale to an AstraZeneca PLC subsidiary, saying the firm wasn't involved.
July 08, 2015
A British biotech company, formerly known as Spirogen Ltd., told a New York federal judge Wednesday that investment banking advisory firm Peter J. Solomon Co. had never worked on its $200 million sale to an AstraZeneca PLC subsidiary, despite the adviser's claim.